NAMS NewAmsterdam Pharma
- 20.200
- +0.080+0.40%
- 20.200
- 0.0000.00%
NewAmsterdam Pharma News
8-K: Current report
8-K: Current report
8-K: Current report
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
8-K: Current report
8-K: Current report
8-K: Current report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Current report
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
NewAmsterdam Pharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NewAmsterdam Pharma | 8-K: Current report
NewAmsterdam Pharma | 8-K: Current report
NewAmsterdam Pharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NewAmsterdam Pharma | 8-K: Current report
NewAmsterdam Pharma | 8-K: Current report
NewAmsterdam Pharma | 8-K: Current report
Analysis
Price Target
No Data
No Data